241 related articles for article (PubMed ID: 33515423)
1. Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis.
Miyazaki C; Sakashita T; Jung W; Kato S
Adv Ther; 2021 May; 38(5):2229-2247. PubMed ID: 33515423
[TBL] [Abstract][Full Text] [Related]
2. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
Mitra D; Hodgkins P; Yen L; Davis KL; Cohen RD
BMC Gastroenterol; 2012 Sep; 12():132. PubMed ID: 23006789
[TBL] [Abstract][Full Text] [Related]
3. Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs.
Dignass A; Waller J; Cappelleri JC; Modesto I; Kisser A; Dietz L; DiBonaventura M; Wood R; May M; Libutzki B; Bargo D
J Med Econ; 2020 Apr; 23(4):415-427. PubMed ID: 31858853
[No Abstract] [Full Text] [Related]
4. Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
Wattanakamolkul K; Nakayama Y
J Med Econ; 2022; 25(1):870-879. PubMed ID: 35703058
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
Cichewicz A; Tencer T; Gupte-Singh K; Egodage S; Burnett H; Kumar J
Adv Ther; 2023 May; 40(5):2116-2146. PubMed ID: 37000363
[TBL] [Abstract][Full Text] [Related]
6. Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016.
Matsuoka K; Igarashi A; Sato N; Isono Y; Gouda M; Iwasaki K; Shoji A; Hisamatsu T
J Crohns Colitis; 2021 Mar; 15(3):358-366. PubMed ID: 32845311
[TBL] [Abstract][Full Text] [Related]
7. Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
Chiorean M; Ha C; Hur P; Sharma PP; Gruben D; Khan NH
Dig Dis Sci; 2023 Oct; 68(10):3985-3993. PubMed ID: 37639057
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.
Hernandez L; Kuwabara H; Shah A; Yamabe K; Burnett H; Fahrbach K; Koufopoulou M; Iwakiri R
Pharmacoeconomics; 2020 Jan; 38(1):69-84. PubMed ID: 31552601
[TBL] [Abstract][Full Text] [Related]
9. Treatment Patterns in Newly Diagnosed Patients with Crohn's Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan.
Hirai F; Uda A; Ota M; Takemura Y; Tanaka K; Iwakiri R
Digestion; 2023; 104(2):109-120. PubMed ID: 36450239
[TBL] [Abstract][Full Text] [Related]
10. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.
Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P
Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006
[No Abstract] [Full Text] [Related]
11. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
12. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis.
Kane SV; Accortt NA; Magowan S; Brixner D
Aliment Pharmacol Ther; 2009 Apr; 29(8):855-62. PubMed ID: 19183154
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
Tada Y; Kim H; Spanopoulos D; Habiro K; Tsuritani K; Yamada Y; Mandal A; Zhong Y; Hikichi Y
J Dermatol; 2022 Nov; 49(11):1106-1117. PubMed ID: 35946343
[TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization and treatment costs of Finnish chronic inflammatory bowel disease patients treated with infliximab
Ylisaukko-Oja T; Torvinen S; Ventola H; Schmidt S; Herrala S; Kononoff J; Voutilainen M
Scand J Gastroenterol; 2019 Jun; 54(6):726-732. PubMed ID: 31203693
[No Abstract] [Full Text] [Related]
15. Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
Nagahori M; Kochi S; Hanai H; Yamamoto T; Nakamura S; Omuro S; Watanabe M; Hibi T;
BMC Gastroenterol; 2017 Apr; 17(1):47. PubMed ID: 28390410
[TBL] [Abstract][Full Text] [Related]
16. Burden of narcolepsy in Japan: A health claims database study evaluating direct medical costs and comorbidities.
Kamada Y; Imanishi A; Chiu SW; Yamaguchi T
Sleep Med; 2024 Feb; 114():119-127. PubMed ID: 38181583
[TBL] [Abstract][Full Text] [Related]
17. Validation of a claims-based algorithm to identify cases of ulcerative colitis in Japan.
Ogino H; Morikubo H; Fukaura K; Okui T; Gardiner S; Sugiyama N; Yoshii N; Kawaguchi T; Chen H; Nonnenmacher E; Setoguchi S; Nakashima N; Kobayashi T
J Gastroenterol Hepatol; 2022 Mar; 37(3):499-506. PubMed ID: 34738649
[TBL] [Abstract][Full Text] [Related]
18. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
Rubin DT; Mody R; Davis KL; Wang CC
Aliment Pharmacol Ther; 2014 May; 39(10):1143-55. PubMed ID: 24697826
[TBL] [Abstract][Full Text] [Related]
19. Trends in the prevalence and incidence of ulcerative colitis in Japan and the US.
Yamazaki M; Chung H; Xu Y; Qiu H
Int J Colorectal Dis; 2023 May; 38(1):135. PubMed ID: 37204516
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
